Cancer Research Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tran, N. L.
Right arrow Articles by Berens, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tran, N. L.
Right arrow Articles by Berens, M. E.
[Cancer Research 66, 9535-9542, October 1, 2006]
© 2006 American Association for Cancer Research


Cell, Tumor, and Stem Cell Biology

Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-{kappa}B and Correlate with Poor Patient Outcome

Nhan L. Tran1, Wendy S. McDonough1, Benjamin A. Savitch1, Shannon P. Fortin1, Jeffrey A. Winkles2, Marc Symons3, Mitsutoshi Nakada1, Heather E. Cunliffe1, Galen Hostetter1, Dominique B. Hoelzinger1, Jessica L. Rennert1, Jennifer S. Michaelson4, Linda C. Burkly4, Christopher A. Lipinski5, Joseph C. Loftus5, Luigi Mariani6 and Michael E. Berens1

1 Cancer and Cell Biology Division, Translational Genomics Research Institute, Phoenix, Arizona; 2 Departments of Surgery and Physiology and the Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, Maryland; 3 Center for Oncology and Cell Biology, The Feinstein Institute for Medical Research at North Shore-Long Island Jewish Health System, Manhasset, New York; 4 Biogen Idec, Inc., Cambridge, Massachusetts; 5 Mayo Clinic Scottsdale, Scottsdale, Arizona; and 6 University Hospital, Inselspital, Bern, Switzerland

Requests for reprints: Michael E. Berens, Cancer and Cell Biology Division, The Translational Genomics Research Institute, 445 North Fifth Street, Phoenix, AZ 85004. Phone: 602-343-8760; Fax: 602-343-8844; E-mail: mberens{at}tgen.org.

Glial tumors progress to malignant grades by heightened proliferation and relentless dispersion throughout the central nervous system. Understanding genetic and biochemical processes that foster these behaviors is likely to reveal specific and effective targets for therapeutic intervention. Our current report shows that the fibroblast growth factor-inducible 14 (Fn14), a member of the tumor necrosis factor (TNF) receptor superfamily, is expressed at high levels in migrating glioma cells in vitro and invading glioma cells in vivo. Forced Fn14 overexpression stimulates glioma cell migration and invasion, and depletion of Rac1 by small interfering RNA inhibits this cellular response. Activation of Fn14 signaling by the ligand TNF-like weak inducer of apoptosis (TWEAK) stimulates migration and up-regulates expression of Fn14; this TWEAK effect requires Rac1 and nuclear factor-{kappa}B (NF-{kappa}B) activity. The Fn14 promoter region contains NF-{kappa}B binding sites, which mediate positive feedback causing sustained overexpression of Fn14 and enduring glioma cell invasion. Furthermore, Fn14 gene expression levels increase with glioma grade and inversely correlate with patient survival. These results show that the Fn14 cascade operates as a positive feedback mechanism for elevated and sustained Fn14 expression. Such a feedback loop argues for aggressive targeting of the Fn14 axis as a unique and specific driver of glioma malignant behavior. (Cancer Res 2006; 66(19): 9535-42)




This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
B. Salhia, N. L. Tran, A. Chan, A. Wolf, M. Nakada, F. Rutka, M. Ennis, W. S. McDonough, M. E. Berens, M. Symons, et al.
The Guanine Nucleotide Exchange Factors Trio, Ect2, and Vav3 Mediate the Invasive Behavior of Glioblastoma
Am. J. Pathol., December 1, 2008; 173(6): 1828 - 1838.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Kotliarova, S. Pastorino, L. C. Kovell, Y. Kotliarov, H. Song, W. Zhang, R. Bailey, D. Maric, J. C. Zenklusen, J. Lee, et al.
Glycogen Synthase Kinase-3 Inhibition Induces Glioma Cell Death through c-MYC, Nuclear Factor-{kappa}B, and Glucose Regulation
Cancer Res., August 15, 2008; 68(16): 6643 - 6651.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
A. L. Willis, N. L. Tran, J. M. Chatigny, N. Charlton, H. Vu, S. A.N. Brown, M. A. Black, W. S. McDonough, S. P. Fortin, J. R. Niska, et al.
The Fibroblast Growth Factor-Inducible 14 Receptor Is Highly Expressed in HER2-Positive Breast Tumors and Regulates Breast Cancer Cell Invasive Capacity
Mol. Cancer Res., May 1, 2008; 6(5): 725 - 734.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Gius, M. C. Funk, E. Y. Chuang, S. Feng, P. C. Huettner, L. Nguyen, C. M. Bradbury, M. Mishra, S. Gao, B. M. Buttin, et al.
Profiling Microdissected Epithelium and Stroma to Model Genomic Signatures for Cervical Carcinogenesis Accommodating for Covariates
Cancer Res., August 1, 2007; 67(15): 7113 - 7123.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. J. Jarzynka, B. Hu, K.-M. Hui, I. Bar-Joseph, W. Gu, T. Hirose, L. B. Haney, K. S. Ravichandran, R. Nishikawa, and S.-Y. Cheng
ELMO1 and Dock180, a Bipartite Rac1 Guanine Nucleotide Exchange Factor, Promote Human Glioma Cell Invasion
Cancer Res., August 1, 2007; 67(15): 7203 - 7211.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. C. Bover, M. Cardo-Vila, A. Kuniyasu, J. Sun, R. Rangel, M. Takeya, B. B. Aggarwal, W. Arap, and R. Pasqualini
A Previously Unrecognized Protein-Protein Interaction between TWEAK and CD163: Potential Biological Implications
J. Immunol., June 15, 2007; 178(12): 8183 - 8194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.